0001654954-20-007918.txt : 20200722 0001654954-20-007918.hdr.sgml : 20200722 20200722170011 ACCESSION NUMBER: 0001654954-20-007918 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200722 DATE AS OF CHANGE: 20200722 EFFECTIVENESS DATE: 20200722 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENAX THERAPEUTICS, INC. CENTRAL INDEX KEY: 0000034956 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 262593535 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-371622 FILM NUMBER: 201041971 BUSINESS ADDRESS: STREET 1: ONE COPLEY PARKWAY STREET 2: SUITE 490 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-806-4414 MAIL ADDRESS: STREET 1: ONE COPLEY PARKWAY STREET 2: SUITE 490 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: OXYGEN BIOTHERAPEUTICS, INC. DATE OF NAME CHANGE: 20080703 FORMER COMPANY: FORMER CONFORMED NAME: SYNTHETIC BLOOD INTERNATIONAL INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SINEQUANON CORP DATE OF NAME CHANGE: 19901219 D 1 primary_doc.xml X0708 D LIVE 0000034956 TENAX THERAPEUTICS, INC. ONE COPLEY PARKWAY ONE COPLEY PARKWAY MORRISVILLE NC NORTH CAROLINA 27560 (919) 855-2100 DELAWARE OXYGEN BIOTHERAPEUTICS, INC. SYNTHETIC BLOOD INTERNATIONAL INC SINEQUANON CORP Corporation true Michael B. Jebsen One Copley Parkway Morrisville NC NORTH CAROLINA 27560 Executive Officer Ronald R. Blanck One Copley Parkway Suite 490 Morrisville NC NORTH CAROLINA 27560 Director Gregory Pepin One Copley Parkway Suite 490 Morrisville NC NORTH CAROLINA 27560 Director James Mitchum One Copley Parkway Suite 490 Morrisville NC NORTH CAROLINA 27560 Director Chris A. Rallis One Copley Parkway Suite 490 Morrisville NC NORTH CAROLINA 27560 Director Gerald Proehl One Copley Parkway Suite 490 Morrisville NC NORTH CAROLINA 27560 Director Anthony DiTonno One Copley Parkway Suite 490 Morrisville NC NORTH CAROLINA 27560 Director Executive Officer Pharmaceuticals Decline to Disclose 06b false 2020-07-08 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 Park Avenue 3rd Floor New York NY NEW YORK 10022 All States Ladenburg Thalmann & Co. Inc. 505 None None 4400 Biscayne Boulevard, 14th Floor Miami FL FLORIDA 33137 All States 5173587 5173587 0 The amount sold reflects the purchase amount of the warrant issued to the investor and the warrant issued to H.C. Wainwright & Co., LLC, the placement agent ol the private placement. false 1 1407900 true 0 Placement Agent received $767,900 in fees and a warrant for 238,194 shares of common stock exercisable at $1.2848/share. Prior placement agent received tail fee of $640,000 and a warrant for 311,344 shares of common stock exercisable at $1.2848/share. 0 A portion of the proceeds may be used for general corporate purposes, including to pay salaries of some related persons listed in Item 3. Tenax Therapeutics, Inc. /s/ Michael B. Jebsen Michael B. Jebsen President and Chief Financial Officer 2020-07-22